Loading clinical trials...
Loading clinical trials...
The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy on Dyspnoea and Activity in Patients With COPD III-IV
The purpose of this study is to determine whether different types of breathing therapies in patients with COPD III-IV decrease dyspnea and increase activity.
In the treatment of COPD-Patients different kinds of breathing therapy techniques are used, but many of them are not reassessed yet. Dyspnea is one of the predominant symptoms of COPD patients and has negative impacts on the activity of the patients. Dyspnea during exertion leads to avoiding activity and results in a deconditioning of muscles and of the cardiovascular system. Thus breathing therapy techniques seem to be useful, which may lead to a decrease of dyspnea and an increase of activity. The purpose of this study is to determine whether reflective breathing therapy is more effective on decreasing dyspnea and increasing activity than conventional breathing therapy.
Age
45 - 75 years
Sex
ALL
Healthy Volunteers
No
Schön Klinik Berchtesgadener Land
Schönau, Bavaria, Germany
Start Date
August 1, 2011
Primary Completion Date
November 1, 2011
Completion Date
November 1, 2011
Last Updated
November 23, 2011
24
ACTUAL participants
conventional breathing therapy
OTHER
reflectory breathing therapy
OTHER
Lead Sponsor
Schön Klinik Berchtesgadener Land
Collaborators
NCT07477600
NCT05878769
NCT06717659
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions